SEER · Healthcare · $118M
$2.15+5.91%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 326 Biotechnology peers
Quarterly Revenue Growth
“매출은 280만 달러에서 310만 달러로 전 분기 대비 반등했지만, 최근 네 분기 흐름은 400만→400만→300만→300만 달러로 아직 회복”
In the company's words · 2026 2분기 earnings call